Genprex (GNPX) Short Interest Ratio & Short Volume $0.91 +0.01 (+1.11%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Genprex Short Interest DataGenprex (GNPX) has a short interest of 433,100 shares, representing 5.43% of the float (the number of shares available for trading by the public). This marks a 26.60% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 2.61 million shares to cover all short positions.Current Short Interest433,100 sharesPrevious Short Interest342,100 sharesChange Vs. Previous Month+26.60%Dollar Volume Sold Short$472,079.00Short Interest Ratio0.0 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares8,508,000 sharesFloat Size7,980,000 sharesShort Percent of Float5.43%Today's Trading Volume339,385 sharesAverage Trading Volume2,607,518 sharesToday's Volume Vs. Average13% Short Selling Genprex? Sign up to receive the latest short interest report for Genprex and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNPX Short Interest Over TimeGNPX Days to Cover Over TimeGNPX Percentage of Float Shorted Over Time Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> Genprex Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024433,100 shares $472,079.00 +26.6%5.4%0 $1.09 11/15/2024342,100 shares $547,360.00 -5.9%4.3%0 $1.60 10/31/2024363,400 shares $817,650.00 +326.5%15.0%0 $2.25 10/15/202485,200 shares $28,490.88 +5.2%3.5%0 $0.33 9/30/202481,000 shares $29,297.70 -66.9%3.3%0.2 $0.36 9/15/2024244,700 shares $102,774.00 +501.2%9.6%0.6 $0.42 Get the Latest News and Ratings for GNPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genprex and its competitors with MarketBeat's FREE daily newsletter. 8/31/202440,700 shares $27,873.40 -83.6%1.6%0.1 $0.68 8/15/2024247,400 shares $161,280.06 +430.9%9.7%1.1 $0.65 7/31/202446,600 shares $78,288.00 -16.6%2.3%0.5 $1.68 7/15/202455,900 shares $111,800.00 +10.5%2.7%0.6 $2.00 6/30/202450,600 shares $95,381.00 -39.2%2.5%0.5 $1.89 6/15/202483,200 shares $180,544.00 +75.9%4.0%0.8 $2.17 5/31/202447,300 shares $147,103.00 +20.1%2.3%0.4 $3.11 5/15/202439,400 shares $96,136.00 -21.2%1.9%0.8 $2.44 4/30/202450,000 shares $113,000.00 +0.6%2.5%0.9 $2.26 4/15/202449,700 shares $119,280.00 -29.0%2.7%0.6 $2.40 3/31/202470,000 shares $208,600.00 -12.8%3.8%0.8 $2.98 3/15/202480,300 shares $324,412.00 +23.7%5.6%1 $4.04 2/29/202464,900 shares $279,070.00 -35.3%4.5%1 $4.30 2/15/2024100,300 shares $439,314.00 +86.1%6.9%2 $4.38 1/31/202453,900 shares $409,640.00 +38.6%3.7%1.1 $7.60 1/15/20241,560,000 shares $339,768.00 +13.9%N/A4.2 $0.22 12/31/20231,370,000 shares $315,100.00 +25.7%N/A3.6 $0.23 12/15/20231,090,000 shares $229,990.00 -7.6%N/A3.3 $0.21 11/30/20231,180,000 shares $285,560.00 -11.9%N/A4 $0.24 11/15/20231,340,000 shares $348,400.00 -18.3%N/A4.5 $0.26 10/31/20231,640,000 shares $362,440.00 -8.9%N/A4.2 $0.22 10/15/20231,800,000 shares $585,000.00 +9.1%N/A4.2 $0.33 9/30/20231,650,000 shares $651,585.00 -6.8%N/A3.1 $0.39 9/15/20231,770,000 shares $901,815.00 +3.5%N/A2.5 $0.51 8/31/20231,710,000 shares $888,687.00 -19.0%N/A2.4 $0.52 8/15/20232,110,000 shares $1.19 million -17.3%N/A2.8 $0.57 7/31/20232,550,000 shares $1.94 million +11.8%N/A3.9 $0.76 7/15/20232,280,000 shares $1.88 million -22.5%N/A3.8 $0.82 6/30/20232,940,000 shares $2.79 million +55.6%N/A4.7 $0.95 6/15/20231,890,000 shares $1.61 million -6.0%N/A4.5 $0.85 5/31/20232,010,000 shares $1.73 million +6.9%N/A4.4 $0.86 5/15/20231,880,000 shares $1.52 million -16.8%N/A3.4 $0.81 4/30/20232,260,000 shares $1.85 million +37.0%N/A4.1 $0.82 4/15/20231,650,000 shares $1.37 million -4.1%N/A3 $0.83Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> 3/31/20231,720,000 shares $1.57 million -11.3%N/A5 $0.91 3/15/20231,940,000 shares $1.60 million -29.2%N/A4.8 $0.83 2/28/20232,740,000 shares $3.51 million +52.2%N/A7.5 $1.28 2/15/20231,800,000 shares $2.86 million +2.9%N/A5.7 $1.59 1/31/20231,750,000 shares $2.57 million +6.1%N/A9.4 $1.47 1/15/20231,650,000 shares $2.36 million +13.0%N/A9.6 $1.43 12/30/20221,460,000 shares $2.12 million -2.0%N/A8.7 $1.45 12/15/20221,490,000 shares $1.77 million -4.5%N/A13.9 $1.19 11/30/20221,560,000 shares $2.11 million +0.7%N/A15.8 $1.35 11/15/20221,550,000 shares $2.09 million -1.9%N/A12.8 $1.35 10/31/20221,580,000 shares $2.15 million -1.9%N/A6.1 $1.36 10/15/20221,610,000 shares $2.14 million -8.0%N/A6 $1.33 9/30/20221,750,000 shares $2.47 million -0.6%N/A6.7 $1.41 9/15/20221,760,000 shares $2.94 million -5.4%N/A6.8 $1.67 8/31/20221,860,000 shares $2.98 million +16.3%N/A7.2 $1.60 8/15/20221,600,000 shares $3.34 million -4.2%N/A6.6 $2.09 7/31/20221,670,000 shares $2.32 million -11.6%N/A15.1 $1.39 7/15/20221,890,000 shares $2.72 million +1.1%N/A16.3 $1.44 6/30/20221,870,000 shares $2.60 million +2.2%N/A13.9 $1.39 6/15/20221,830,000 shares $2.49 million -9.9%N/A12 $1.36 5/31/20222,030,000 shares $2.98 million +5.2%N/A10.1 $1.47 5/15/20221,930,000 shares $2.93 million -1.0%N/A7 $1.52 4/30/20221,950,000 shares $3.12 million -3.0%N/A5.6 $1.60 4/15/20222,010,000 shares $4.00 million +8.1%N/A3.5 $1.99 3/31/20221,860,000 shares $4.20 million -3.1%N/A1.4 $2.26 3/15/20221,920,000 shares $3.88 million -20.0%N/A0.3 $2.02 2/28/20222,400,000 shares $5.47 million -19.2%N/A0.4 $2.28 2/15/20222,970,000 shares $7.01 million -13.2%N/A0.5 $2.36 1/31/20223,420,000 shares $6.81 million -23.8%N/A0.6 $1.99 1/15/20224,490,000 shares $10.15 million +113.8%N/A0.7 $2.26 12/31/20212,100,000 shares $2.75 million -3.7%N/A0.4 $1.31 12/15/20212,180,000 shares $2.83 million -1.4%N/A5.1 $1.30 11/30/20212,210,000 shares $3.20 million -2.6%N/A5.4 $1.45 11/15/20212,270,000 shares $4.65 million -0.9%N/A5.7 $2.05 10/29/20212,290,000 shares $5.34 million +2.7%N/A6.1 $2.33 10/15/20212,230,000 shares $5.37 million -2.6%N/A5.7 $2.41 9/30/20212,290,000 shares $6.14 million -2.6%N/A6 $2.68 9/15/20212,350,000 shares $6.51 million +2.6%N/A4.8 $2.77 8/31/20212,290,000 shares $7.21 million -2.6%N/A4.3 $3.15 8/13/20212,350,000 shares $6.49 million -10.0%N/A4.1 $2.76 7/30/20212,610,000 shares $7.73 million -6.5%N/A4.5 $2.96 7/15/20212,790,000 shares $8.15 million No Change6.6%4.5 $2.92 6/30/20212,790,000 shares $9.35 million -24.8%6.6%4 $3.35 6/15/20213,710,000 shares $13.21 million -7.3%8.8%5.1 $3.56 5/28/20214,000,000 shares $14.96 million -2.7%9.4%5.2 $3.74 5/14/20214,110,000 shares $12.78 million -1.4%N/A4.4 $3.11 4/30/20214,170,000 shares $16.30 million No ChangeN/A3.7 $3.91 4/15/20214,170,000 shares $16.97 million -3.9%N/A2.9 $4.07 3/31/20214,340,000 shares $17.66 million +24.4%N/A2.9 $4.07 3/15/20213,490,000 shares $18.43 million +9.8%N/A1.9 $5.28Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> 2/26/20213,180,000 shares $16.89 million -2.8%N/A1.8 $5.31 2/12/20213,270,000 shares $22.82 million -22.0%N/A1.9 $6.98 1/29/20214,190,000 shares $18.73 million +3.7%N/A2.7 $4.47 1/15/20214,040,000 shares $15.47 million +27.0%N/A3.1 $3.83 12/31/20203,180,000 shares $14.06 million +0.6%N/A2.9 $4.42 12/15/20203,160,000 shares $10.40 million -6.2%N/A3.3 $3.29 11/30/20203,370,000 shares $10.41 million +12.3%N/A5.4 $3.09 11/15/20203,000,000 shares $9.48 million -1.0%N/A4.2 $3.16 10/30/20203,030,000 shares $10.70 million +2.0%N/A3.4 $3.53 10/15/20202,970,000 shares $10.96 million -5.7%N/A3.3 $3.69 9/30/20203,150,000 shares $10.58 million -9.2%N/A2.5 $3.36 9/15/20203,470,000 shares $13.12 million -8.9%N/A2.3 $3.78 8/31/20203,810,000 shares $15.09 million +7.3%N/A2.3 $3.96 8/14/20203,550,000 shares $15.23 million -9.9%N/A2 $4.29 7/31/20203,940,000 shares $13.28 million +1.8%N/A2.3 $3.37 7/15/20203,870,000 shares $11.46 million -4.2%N/A1.4 $2.96 6/30/20204,040,000 shares $12.69 million +24.3%N/A1.5 $3.14 6/15/20203,250,000 shares $9.82 million +6.9%N/A1.3 $3.02 5/29/20203,040,000 shares $8.42 million -24.6%N/A1.1 $2.77 5/15/20204,030,000 shares $13.10 million +10.4%N/A1.3 $3.25 4/30/20203,650,000 shares $8.10 million +102.8%N/A0.6 $2.22 4/15/20201,800,000 shares $3.85 million +37.4%N/A0.3 $2.14 3/31/20201,310,000 shares $2.97 million +20.9%N/A0.2 $2.27 3/13/20201,083,900 shares $2.35 million -43.3%N/A0.4 $2.17 2/28/20201,910,000 shares $4.34 million +5.0%N/A0.3 $2.27 2/14/20201,820,000 shares $5.06 million +7.1%N/A0.3 $2.78 1/31/20201,700,000 shares $8.13 million +143.7%N/A0.5 $4.78 1/15/2020697,600 shares $1.12 million +79.1%5.3%0.3 $1.61 12/31/2019389,600 shares $498,688.00 +7.8%3.5%0.6 $1.28 GNPX Short Interest - Frequently Asked Questions What is Genprex's current short interest? Short interest is the volume of Genprex shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 433,100 shares of GNPX short. 5.43% of Genprex's shares are currently sold short. Learn More on Genprex's current short interest. What is a good short interest percentage for Genprex? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.43% of Genprex's floating shares are currently sold short. Is Genprex's short interest increasing or decreasing? Genprex saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 433,100 shares, an increase of 26.6% from the previous total of 342,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Genprex's float size? Genprex currently has issued a total of 8,508,000 shares. Some of Genprex's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Genprex currently has a public float of 7,980,000 shares. How does Genprex's short interest compare to its competitors? 5.43% of Genprex's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genprex: OKYO Pharma Limited (1.00%), Anebulo Pharmaceuticals, Inc. (0.07%), Affimed (4.70%), Outlook Therapeutics, Inc. (27.12%), Verrica Pharmaceuticals Inc. (6.67%), Incannex Healthcare Inc. (0.21%), Surrozen, Inc. (1.43%), RAPT Therapeutics, Inc. (3.92%), RenovoRx, Inc. (0.38%), ProMIS Neurosciences, Inc. (0.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Genprex stock? Short selling GNPX is an investing strategy that aims to generate trading profit from Genprex as its price is falling. GNPX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genprex? A short squeeze for Genprex occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNPX, which in turn drives the price of the stock up even further. How often is Genprex's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNPX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies OKYO Pharma Short Squeeze Anebulo Pharmaceuticals Short Squeeze Affimed Short Squeeze Outlook Therapeutics Short Squeeze Verrica Pharmaceuticals Short Squeeze Incannex Healthcare Short Squeeze Surrozen Short Squeeze RAPT Therapeutics Short Squeeze RenovoRx Short Squeeze ProMIS Neurosciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNPX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genprex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genprex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNPX Stock Alerts